Evid Invest
Who owns ARQTWhat ARQT owns — n/a

Who owns Arcutis Biotherapeutics, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of ARQT from SEC Form 13F filings across 294 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 294 institutions disclosed 149.0M shares of Arcutis Biotherapeutics, Inc. worth $3.96B — about 113.7% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.

294

13F holders

$3.96B

value, 2026 filers

113.7%

of shares outstanding (149.0M sh)

65

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of ARQT's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1BlackRock, Inc.19.2M$506.7M0.0%14.6%+81.8%
2MONTANOVA CAPITAL, LLC12.3M$324.3M7.5%9.4%-1.4%
3Frazier Life Sciences Management, L.P.9.9M$261.0M6.5%7.5%0.0%
4Rubric Capital Management LP8.4M$222.6M2.1%6.4%+1.8%
5STATE STREET CORP7.7M$204.0M0.0%5.9%+32.6%
6Polar Capital Holdings Plc6.6M$174.2M0.4%5%-0.2%
7UBS Group AG5.5M$146.2M0.0%4.2%+66.0%
8MORGAN STANLEY5.3M$140.0M0.0%4%+19.0%
9VANGUARD CAPITAL MANAGEMENT LLC5.0M$132.0M0.0%3.8%+0.1%
10VANGUARD PORTFOLIO MANAGEMENT LLC3.8M$100.9M0.0%2.9%+57.2%
11BANK OF AMERICA CORP /DE/3.5M$92.3M0.0%2.7%+17.0%
12JENNISON ASSOCIATES LLC3.3M$88.1M0.1%2.5%-21.0%
13ORBIMED ADVISORS LLC3.1M$82.5M1.5%2.4%+52.9%
14GEODE CAPITAL MANAGEMENT, LLC3.0M$78.5M0.0%2.3%-0.4%
15D. E. Shaw & Co., Inc.2.6M$69.9M0.0%2%-33.0%
16FRANKLIN TEMPLETON INC2.0M$67.4M0.0%1.5%+2.4%
17AMERICAN CENTURY COMPANIES INC2.0M$52.2M0.0%1.5%+2.6%
18GOLDMAN SACHS GROUP INC1.6M$43.6M0.0%1.3%-1.2%
19INFINITUM ASSET MANAGEMENT, LLCNEW1.6M$42.3M3.7%1.2%new
20CITADEL ADVISORS LLC1.5M$40.5M0.0%1.2%+32.0%
21OBERWEIS ASSET MANAGEMENT INC/1.5M$40.2M0.9%1.2%+10.8%
22Janus Henderson Group Ltd.NEW1.4M$35.9M0.0%1%new
23GW&K Investment Management, LLC1.4M$35.7M0.3%1%+5.0%
24BAMCO INC /NY/1.2M$32.2M0.1%0.9%-2.8%
25Aberdeen Group plc1.2M$31.8M0.0%0.9%+9.7%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.